Biotech Santé Bretagne (BSB) functions as Bretagne's biotech and health cluster and a leading innovation center focusing on seven key markets: eco-industries, agro-industry, food, cosmetic, biotech/pharma, medical technologies, and e-health. Their primary role is to develop and implement strategies for the region's biotech and health sectors, offering support for pioneering initiatives from innovation to industrialization and market entry. This support includes consultancy, introductions to relevant networks, feasibility studies, guidance on finance and funding, regulatory navigation, scientific and technological intelligence, and European market assistance. BSB's strategy involves actively promoting innovation through business networking and technical events, facilitating access to regional biotech and health resources, including businesses, research centers, and emerging innovations. They aim to accelerate innovations by connecting stakeholders and helping them find the right connections within the Bretagne region and beyond. The cluster actively participates in European projects, such as Biochains Atlantic, DigiH4A, and ACE, focusing on areas like seaweed industry development, digital health market access, and home care innovation. BSB's commitment is centered on fostering the growth of the biotech and health sectors in Bretagne through strategic collaborations, knowledge dissemination, and project development. They emphasize values such as confidentiality, trust, responsiveness, and a service-oriented approach in their interactions with partners and stakeholders. The cluster serves as a facilitator and accelerator, leveraging regional strengths and participating in international collaborations to drive innovation and market success for biotech and health-related initiatives in the region. They also act as a gateway to understanding the Bretagne region's biotech and health innovation ecosystem. Overall, Biotech Santé Bretagne operates as a regional innovation hub, providing resources, connections, and strategic support to companies and researchers in the biotech and health sectors, with a strong emphasis on collaborative projects and European partnerships. Their involvement in various initiatives demonstrates their dedication to enhancing the innovation ecosystem and fostering growth within the specific markets they focus on.
Preferred startup development maturity for initial funding deployment.
Eco-industries, Agro-industry, Food, Cosmetic, Biotech/pharma, Medical Technologies, E-health
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...